This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mesalamine DR 400 mg capsules (180s). The contract has a ceiling value of $2,632.04 and a completion date of June 13, 2025. The award is not set aside and was made on June 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00,...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of Mesalamine ER 0.375 gram capsules. The contract has a potential value of $5,915.13 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. Amerisourcebergen Drug Corp also holds an...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Mesalamine Extended-Release 0.375 gram capsules in packages of 120. The contract has a ceiling value of $1,362.68 and a period of performance through May 13, 2025. There is no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 180 capsules of 400 mg Mesalamine DR (delayed release) with a ceiling value of $5,439.88. The contract has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Mesalamine ER 0.375 gram capsules, a pharmaceutical product used in the treatment of various medical conditions. The contract is a firm fixed-price delivery order with a ceiling value of $7,326.30 and a performance period through December 20, 2024. The contract is not...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Mesalamine DR 400 mg Capsule (180s). The contract has a ceiling value of $2,666.26 and an ultimate completion date of May 23, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 tablets of the medication Mesalamine Delayed-Release 1.2 gram, with a ceiling value of $2,180.50 and a completion date of June 5, 2025. The contract is not set aside for any special designation. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Mesalamine ER 0.375 gram capsules. The contract, valued at $4,269.16, was awarded on June 24, 2024 by the Medical Supply Chain division of the Defense Logistics Agency (DLA). It is a Firm Fixed Price Delivery Order contract with a completion date of June 25, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,698.11, is for the delivery of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 23, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,093,215 units of Mesalamine DR 400 mg capsules. The contract has a ceiling value of $4,230.04 and a performance period through May 1, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...